Trial Profile
Pilot Study of the Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Scleritis
- Focus Therapeutic Use
- 31 Jan 2017 New trial record